Reinhard Zeidler

Summary

Affiliation: GSF-National Research Center for Environment and Health
Country: Germany

Publications

  1. ncbi Nicotine and apoptosis
    Reinhard Zeidler
    ENT Department, University of Munich, c o GSF Forschungszentrum, Marchioninistr 25, 81377 Munich, Germany
    Apoptosis 12:1927-43. 2007
  2. ncbi Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV
    Martin Schlee
    Institute of Clinical Molecular Biology and Tumor Genetics, GSF National Research Center for EnvironmentHealth, Munich, Germany
    J Virol 78:3941-52. 2004
  3. ncbi The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP
    Markus Munz
    Head and Neck Research Department, Clinical Cooperation Group Molecular Oncology, GSF, National Research Center for Environment and Health, Marchioninistr 15, 81377 Munich, Germany
    Cancer Lett 225:151-7. 2005
  4. ncbi B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells
    Andreas Moosmann
    Department of Otorhinolaryngology, Ludwig Maximilians Universitat, Munich, Germany
    Blood 100:1755-64. 2002
  5. ncbi Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines
    Martina Wiesner
    Department of Gene Vectors, GSF - National Research Center for Environment and Health, Munich, Germany
    Eur J Immunol 35:2110-21. 2005
  6. ncbi Carcinoma-associated eIF3i overexpression facilitates mTOR-dependent growth transformation
    Martin Ahlemann
    Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital of Schleswig Holstein, Campus Luebeck, Luebeck, Germany
    Mol Carcinog 45:957-67. 2006
  7. ncbi Activated B cells mediate efficient expansion of rare antigen-specific T cells
    Caroline Zentz
    Clinical Cooperative Group Molecular Oncology, GSF National Research Center for Environment and Health, Munich, Germany
    Hum Immunol 68:75-85. 2007
  8. ncbi Molecular profiling for the identification of new biomarkers in smokers and cancer patients
    Kaj Albermann
    Biomax Informatics AG, D 82152 Martinsried, Germany
    Cancer Genomics Proteomics 4:349-58. 2007
  9. ncbi Conditional immortalization of human B cells by CD40 ligation
    Martina Wiesner
    Clinical Cooperative Group Molecular Oncology, GSF National Research Center, Ludwig Maximilians Universitat, Munich, Germany
    PLoS ONE 3:e1464. 2008

Collaborators

  • Markus Munz
  • Georg W Bornkamm
  • Andreas Moosmann
  • Martina Wiesner
  • Caroline Zentz
  • Wolfgang Hammerschmidt
  • Kaj Albermann
  • Stephan Lang
  • Martin Ahlemann
  • Olivier Gires
  • Martin Schlee
  • Christine Mayr
  • Rainer Wimmer
  • Barbara Wollenberg
  • Bernhard Frankenberger
  • Stephen Man
  • Peter Hillemanns
  • Brigitte Mack
  • Hans-Jochem Kolb
  • Mark Cobbold
  • Florian Kern
  • Markus H Hammer
  • Reinhard Mailhammer
  • Josip Lovric
  • Guido Sauer
  • Gerhard Laux
  • Tanja Krug

Detail Information

Publications9

  1. ncbi Nicotine and apoptosis
    Reinhard Zeidler
    ENT Department, University of Munich, c o GSF Forschungszentrum, Marchioninistr 25, 81377 Munich, Germany
    Apoptosis 12:1927-43. 2007
    ..This review provides an overlook how nicotine influences apoptotic processes and is thus directly involved in the etiology of pathological conditions like cancer and obstructive diseases...
  2. ncbi Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV
    Martin Schlee
    Institute of Clinical Molecular Biology and Tumor Genetics, GSF National Research Center for EnvironmentHealth, Munich, Germany
    J Virol 78:3941-52. 2004
    ..These findings underscore the value of EREB2-5 cells as an appropriate model system for the analysis of early events in the process of EBV-mediated B-cell immortalization...
  3. ncbi The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP
    Markus Munz
    Head and Neck Research Department, Clinical Cooperation Group Molecular Oncology, GSF, National Research Center for Environment and Health, Marchioninistr 15, 81377 Munich, Germany
    Cancer Lett 225:151-7. 2005
    ..Taken together, these results provide further evidence for the direct involvement of EpCAM in signalling processes, gene regulation, and cellular metabolism supporting its important role in tumour biology...
  4. ncbi B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells
    Andreas Moosmann
    Department of Otorhinolaryngology, Ludwig Maximilians Universitat, Munich, Germany
    Blood 100:1755-64. 2002
    ..We conclude that the pp65 mini-EBV is an attractive tool for CMV-specific adoptive immunotherapy. Mini-EBVs could also facilitate the generation of T cells specific for various other antigens of interest...
  5. ncbi Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines
    Martina Wiesner
    Department of Gene Vectors, GSF - National Research Center for Environment and Health, Munich, Germany
    Eur J Immunol 35:2110-21. 2005
    ..Using a peptide library covering the pp65 sequence for further analysis of T cell clones, we identified new pp65 CD8(+) and CD4(+) T cell epitopes...
  6. ncbi Carcinoma-associated eIF3i overexpression facilitates mTOR-dependent growth transformation
    Martin Ahlemann
    Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital of Schleswig Holstein, Campus Luebeck, Luebeck, Germany
    Mol Carcinog 45:957-67. 2006
    ..Thus, eIF3i overexpression fosters the integration of growth signals by mTOR into the mRNA translation process, promoting protein synthesis and tumor growth...
  7. ncbi Activated B cells mediate efficient expansion of rare antigen-specific T cells
    Caroline Zentz
    Clinical Cooperative Group Molecular Oncology, GSF National Research Center for Environment and Health, Munich, Germany
    Hum Immunol 68:75-85. 2007
    ..These results strongly encourage the use of CD40-stimulated B cells as APCs in immunotherapy...
  8. ncbi Molecular profiling for the identification of new biomarkers in smokers and cancer patients
    Kaj Albermann
    Biomax Informatics AG, D 82152 Martinsried, Germany
    Cancer Genomics Proteomics 4:349-58. 2007
    ..This review is a short survey of these investigations and how they have contributed to the detection of new biomarkers and to a better understanding of smoking-induced harm...
  9. ncbi Conditional immortalization of human B cells by CD40 ligation
    Martina Wiesner
    Clinical Cooperative Group Molecular Oncology, GSF National Research Center, Ludwig Maximilians Universitat, Munich, Germany
    PLoS ONE 3:e1464. 2008
    ..Conditionally immortalized human B cells are a new tool for immunotherapy and studies of B cell oncogenesis, activation, and function...